Gene · 57794
NIH grants2,660
NIH grants whose papers are about the gene, through NIH's grant-paper links.
261 to 280 of 2,660
Download this page as JSON| Grant | Title | SUGP1 papers | Newest fiscal year |
|---|---|---|---|
| R01CA096899 | Mechanism(s) of TAL1- and NOTCH1-mediated Leukemogenesis | 1 | 2025 |
| R01CA097098 | Targeting the MUC1-C Oncoprotein in Triple-Negative Breast Cancer | 1 | 2025 |
| R01CA148761 | Therapeutic Targeting of Breast Cancer Tumor Initiating Cells | 1 | 2025 |
| R01CA163336 | Predicting Transcriptional and Epigenetic Networks in Cancer from Sequencing Data | 1 | 2025 |
| R01CA176111 | Preventing MAPK inhibitor resistance in melanoma by targeting genomic instability and immune resistance | 1 | 2025 |
| R01CA186702 | Mechanisms of epitranscriptomic regulation in cancer | 1 | 2025 |
| R01CA193466 | Computational and Experimental Modeling of Alternative Polyadenylation | 1 | 2025 |
| R01CA196740 | The role of PTEN feedback mechanism in cancer | 1 | 2025 |
| R01CA206458 | Exosome secretion in breast cancer progression | 1 | 2025 |
| R01CA215226 | Therapeutic Targeting of RNA Splicing in Triple-Negative Breast Cancer | 1 | 2025 |
| R01CA238249 | Integrated ligand and target discovery by chemical proteomics for glioblastoma treatment. | 1 | 2025 |
| R01CA240290 | Novel Therapeutic Strategies to Co-Target Undifferentiated Prostate Cancer (PCa) Stem Cells and Bulk PCa Cells | 1 | 2025 |
| R01CA246130 | Dissecting and Targeting RB1-Mutant Osteosarcoma | 1 | 2025 |
| R01CA248317 | MYC-regulated RNA Binding Protein Networks and Spliced Isoforms Driving Cancer | 1 | 2025 |
| R01CA249424 | Regulation of extracellular vesicle biogenesis through cell adhesion | 1 | 2025 |
| R01CA249684 | Exosomes in HNSCC Progression | 1 | 2025 |
| R01CA258100 | Targeting m6A RNA epigenetics in treatment-emergent neuroendocrine prostate cancer | 1 | 2025 |
| R01CA258300 | Covalent Protein Binders for Cancer Research and Therapy | 1 | 2025 |
| R01CA259124 | Chitinase-3-like-1 mediated immunosuppression in Glioblastoma | 1 | 2025 |
| R01CA261258 | Human papillomavirus in HIV associated lung cancers | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57794/grants?page=14